WebMay 6, 2014 · In the CYCLOPS study in AAV, no difference was observed in the rate of remission between the intravenous and oral cyclophosphamide groups. 37 However, the long-term analysis (average follow-up 4.3 ... WebOct 16, 2024 · Background: The study aimed at studying efficacy and adverse effects of pulse cyclophosphamide (pCyc) treatment and to compare it to continuous cyclophosphamide (cCyc) for induction of remission in ANCA-associated vasculitides from data in the published literature. Methods: A Medline search identified 14 studies, …
Rituximab or Cyclophosphamide in the Treatment of Membranous ... - PubMed
WebThe rituximab-based regimen was more efficacious than the cyclophosphamide-based regimen for inducing remission of relapsing disease; 34 of 51 patients in the rituximab group (67%) as compared... WebMar 1, 2024 · Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial - PMC Back to Top Skip to main content An official website of the United States government Here's how you know The .gov means it’s official. Federal government websites often end in .gov or .mil. great lakes baptist district
Frontiers New Insights Into Novel Therapeutic Targets in …
WebMethods: We randomly assigned 74 adults with membranous nephropathy and proteinuria >3.5 g/d to rituximab (1 g) on days 1 and 15, or a 6-month cyclic regimen with … WebDec 15, 2024 · Cyclophosphamide is given either by daily oral (PO) or pulsed intravenous (IV) administration. The pulsed IV route is considered to have less toxicity; and CYCLOPS, an international, multi-centre clinical trial ( n = 149) comparing the two regimens, demonstrated that both treatment routes were equally efficacious. WebJun 26, 2014 · Cumulative doses of cyclophosphamide in our study were lower than those reported in patients before publication of CYCAZAREM [7] and CY-CLOPS [18,19] results and comparable to or even lower than ... great lakes bank routing number